Weight-Space Programming is a paradigm shift for AI engineering and the key discovery that leads to RSI and potentially even ...
The Trinity is a recursive self-improvement framework that couples world generation with agent Harness evolution. It organizes heterogeneous multimodal tasks by shared capability requirements and ...
If you enjoy this project and want to support the ongoing development, reverse engineering, and optimization of The Order: 1886 PC Native Port, consider buying me a coffee! Every contribution ...
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Membership today. It is, perhaps, the ultimate promise of artificial intelligence: AI systems ...
“Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating exponential new progress — and risk. Jeff Clune, a computer scientist and ...
How do you get from a chatbot that sometimes makes things up to a machine that humans might struggle to control? There are several steps in that argument, and plenty of uncertainty. But an idea known ...
Anthropic and OpenAI researchers raised fresh concerns about recursive self-improvement, the process by which AI helps improve the development of models. Both OpenAI and Anthropic have in recent ...
原创 最新推荐文章于 2026-09-15 13:22:05 发布 · 324 阅读 最近在论坛上看到一个挺火的帖子,叫“人狗大作战python代码2023”,点进去一看,核心玩法其实就是队伍搭配和技能释放顺序的排列组合问题。
AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...
Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results